Others

Brawn Biotech Ltd. - Outcome of Board Meeting

| Updated on May 22, 2019 Published on May 22, 2019

Pursuant to provisions of Regulation 30 and 33 and any other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,(hereinafter SEBI Listing Regulations, this is to inform that the Board of Directors of the Company in its meeting held today, i.e. 22nd day of May, 2019 have inter- alia considered, approved and taken on record the followings:-

The audited standalone financial results along with Statement of Assets & Liabilities of the Company for the fourth quarter(Q4) and financial year ended 31st March, 2019, which was recommended by the Audit Committee at their meeting held on May 22nd, 2019, copies whereof alongwith audit report for standalone results and declaration by the Chief Financial Officer of the Company in terms of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pdf Link: Brawn Biotech Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on May 22, 2019
This article is closed for comments.
Please Email the Editor